Therapeutic APAC molecules comprising heparin conjugated to plasma proteins

摘要

The present invention relates to an antithrombotic molecule having both antiplatelet and anticoagulant (APAC) activity; its use as a medicament; its selective structure and use as an anticoagulant and platelet inhibitor, or predominantly an anticoagulant. Alternatively, it relates to its selective structure and use as either a platelet inhibitor and a method for its production.